nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Skin exfoliation—Desonide—atopic dermatitis	0.0123	0.0311	CcSEcCtD
Terlipressin—Skin exfoliation—Fluocinonide—atopic dermatitis	0.00993	0.0252	CcSEcCtD
Terlipressin—Skin exfoliation—Pimecrolimus—atopic dermatitis	0.00866	0.0219	CcSEcCtD
Terlipressin—Fluid overload—Tacrolimus—atopic dermatitis	0.00794	0.0201	CcSEcCtD
Terlipressin—Respiratory distress—Tacrolimus—atopic dermatitis	0.00777	0.0197	CcSEcCtD
Terlipressin—Torsade de pointes—Tacrolimus—atopic dermatitis	0.00704	0.0178	CcSEcCtD
Terlipressin—Ventricular fibrillation—Tacrolimus—atopic dermatitis	0.00644	0.0163	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Tacrolimus—atopic dermatitis	0.00546	0.0138	CcSEcCtD
Terlipressin—Respiratory failure—Tacrolimus—atopic dermatitis	0.00503	0.0127	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Desonide—atopic dermatitis	0.00475	0.012	CcSEcCtD
Terlipressin—Nervous system disorder—Desonide—atopic dermatitis	0.00449	0.0114	CcSEcCtD
Terlipressin—Skin disorder—Desonide—atopic dermatitis	0.00445	0.0113	CcSEcCtD
Terlipressin—AVPR1A—Peptide GPCRs—CCR5—atopic dermatitis	0.00443	0.00732	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00443	0.00732	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00443	0.00732	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00441	0.00728	CbGpPWpGaD
Terlipressin—AVPR2—Peptide GPCRs—CCR5—atopic dermatitis	0.0044	0.00726	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Tacrolimus—atopic dermatitis	0.00439	0.0111	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00433	0.00715	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.0043	0.0071	CbGpPWpGaD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00429	0.00709	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CCL17—atopic dermatitis	0.00426	0.00704	CbGpPWpGaD
Terlipressin—Malnutrition—Pimecrolimus—atopic dermatitis	0.00397	0.01	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00388	0.00641	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00388	0.0064	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00385	0.00637	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—atopic dermatitis	0.00385	0.00974	CcSEcCtD
Terlipressin—Hot flush—Tacrolimus—atopic dermatitis	0.00383	0.0097	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.0038	0.00628	CbGpPWpGaD
Terlipressin—Menopausal symptoms—Tacrolimus—atopic dermatitis	0.0038	0.00962	CcSEcCtD
Terlipressin—Atrial fibrillation—Tacrolimus—atopic dermatitis	0.00378	0.00958	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00377	0.00624	CbGpPWpGaD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00375	0.0062	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCL22—atopic dermatitis	0.0037	0.00611	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00368	0.00608	CbGpPWpGaD
Terlipressin—Cardiac failure—Tacrolimus—atopic dermatitis	0.00367	0.0093	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—CCL22—atopic dermatitis	0.00367	0.00606	CbGpPWpGaD
Terlipressin—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00364	0.00922	CcSEcCtD
Terlipressin—Skin disorder—Fluocinonide—atopic dermatitis	0.00361	0.00914	CcSEcCtD
Terlipressin—Hyponatraemia—Tacrolimus—atopic dermatitis	0.0036	0.00911	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CCL11—atopic dermatitis	0.00344	0.00568	CbGpPWpGaD
Terlipressin—AVPR1A—G alpha (q) signalling events—NPS—atopic dermatitis	0.00343	0.00567	CbGpPWpGaD
Terlipressin—AVPR1A—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00343	0.00567	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00339	0.0056	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00339	0.0056	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00336	0.00556	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00336	0.00556	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Pimecrolimus—atopic dermatitis	0.00335	0.00849	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00334	0.00551	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00332	0.00549	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.0033	0.00545	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCL27—atopic dermatitis	0.0033	0.00544	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00328	0.00542	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00328	0.00542	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL27—atopic dermatitis	0.00327	0.0054	CbGpPWpGaD
Terlipressin—Tachycardia—Diphenhydramine—atopic dermatitis	0.00327	0.00828	CcSEcCtD
Terlipressin—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00327	0.00828	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00322	0.00531	CbGpPWpGaD
Terlipressin—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00317	0.00804	CcSEcCtD
Terlipressin—Skin disorder—Pimecrolimus—atopic dermatitis	0.00314	0.00796	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00313	0.00517	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00311	0.00513	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00307	0.00507	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00307	0.00507	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00301	0.00496	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00298	0.00492	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCL17—atopic dermatitis	0.00296	0.00488	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00296	0.00488	CbGpPWpGaD
Terlipressin—Skin exfoliation—Hydrocortisone—atopic dermatitis	0.00294	0.00745	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—CCL17—atopic dermatitis	0.00293	0.00485	CbGpPWpGaD
Terlipressin—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00289	0.00731	CcSEcCtD
Terlipressin—Headache—Desonide—atopic dermatitis	0.00287	0.00727	CcSEcCtD
Terlipressin—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.00284	0.00719	CcSEcCtD
Terlipressin—Pulmonary oedema—Prednisolone—atopic dermatitis	0.00281	0.00711	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CCR3—atopic dermatitis	0.0028	0.00463	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00279	0.00708	CcSEcCtD
Terlipressin—Skin exfoliation—Triamcinolone—atopic dermatitis	0.00277	0.00701	CcSEcCtD
Terlipressin—Skin exfoliation—Methylprednisolone—atopic dermatitis	0.00276	0.007	CcSEcCtD
Terlipressin—Pulmonary oedema—Hydrocortisone—atopic dermatitis	0.00274	0.00694	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CCL22—atopic dermatitis	0.00274	0.00452	CbGpPWpGaD
Terlipressin—Hypertension—Loratadine—atopic dermatitis	0.00273	0.00691	CcSEcCtD
Terlipressin—Acute coronary syndrome—Tacrolimus—atopic dermatitis	0.00272	0.0069	CcSEcCtD
Terlipressin—Myocardial infarction—Tacrolimus—atopic dermatitis	0.00271	0.00686	CcSEcCtD
Terlipressin—Chest pain—Loratadine—atopic dermatitis	0.00269	0.00681	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CCL27—atopic dermatitis	0.00269	0.00444	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00269	0.00444	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.00267	0.00677	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00267	0.00441	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.0026	0.0043	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.0026	0.00429	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00258	0.00427	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Triamcinolone—atopic dermatitis	0.00258	0.00654	CcSEcCtD
Terlipressin—Pulmonary oedema—Methylprednisolone—atopic dermatitis	0.00257	0.00652	CcSEcCtD
Terlipressin—Abdominal pain—Pimecrolimus—atopic dermatitis	0.00256	0.00648	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00255	0.00421	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00253	0.00418	CbGpPWpGaD
Terlipressin—Nervous system disorder—Loratadine—atopic dermatitis	0.00253	0.00641	CcSEcCtD
Terlipressin—Bradycardia—Tacrolimus—atopic dermatitis	0.00252	0.00639	CcSEcCtD
Terlipressin—Tachycardia—Loratadine—atopic dermatitis	0.00252	0.00637	CcSEcCtD
Terlipressin—Skin exfoliation—Dexamethasone—atopic dermatitis	0.00251	0.00636	CcSEcCtD
Terlipressin—Skin exfoliation—Betamethasone—atopic dermatitis	0.00251	0.00636	CcSEcCtD
Terlipressin—Skin disorder—Loratadine—atopic dermatitis	0.0025	0.00634	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—TAC1—atopic dermatitis	0.0025	0.00413	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—NPS—atopic dermatitis	0.0025	0.00413	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CXCR3—atopic dermatitis	0.00245	0.00405	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL27—atopic dermatitis	0.00244	0.00403	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCL11—atopic dermatitis	0.00238	0.00394	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL11—atopic dermatitis	0.00237	0.00391	CbGpPWpGaD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00235	0.00389	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Betamethasone—atopic dermatitis	0.00234	0.00593	CcSEcCtD
Terlipressin—Pulmonary oedema—Dexamethasone—atopic dermatitis	0.00234	0.00593	CcSEcCtD
Terlipressin—Headache—Fluocinonide—atopic dermatitis	0.00233	0.00589	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00231	0.00382	CbGpPWpGaD
Terlipressin—Chest pain—Mometasone—atopic dermatitis	0.00231	0.00585	CcSEcCtD
Terlipressin—Cardiac disorder—Tacrolimus—atopic dermatitis	0.0023	0.00583	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.0023	0.00379	CbGpPWpGaD
Terlipressin—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00229	0.0058	CcSEcCtD
Terlipressin—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00229	0.0058	CcSEcCtD
Terlipressin—Cardiac failure—Hydrocortisone—atopic dermatitis	0.00229	0.0058	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00227	0.00376	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00227	0.00376	CbGpPWpGaD
Terlipressin—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00227	0.00576	CcSEcCtD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00226	0.00373	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00226	0.00373	CbGpPWpGaD
Terlipressin—Angiopathy—Tacrolimus—atopic dermatitis	0.00225	0.0057	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00224	0.0037	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00223	0.00368	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00223	0.00564	CcSEcCtD
Terlipressin—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00221	0.00561	CcSEcCtD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00221	0.00366	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL17—atopic dermatitis	0.00219	0.00361	CbGpPWpGaD
Terlipressin—Skin exfoliation—Prednisone—atopic dermatitis	0.00219	0.00554	CcSEcCtD
Terlipressin—Malnutrition—Tacrolimus—atopic dermatitis	0.00216	0.00547	CcSEcCtD
Terlipressin—Cardiac failure—Methylprednisolone—atopic dermatitis	0.00215	0.00545	CcSEcCtD
Terlipressin—Vomiting—Dimenhydrinate—atopic dermatitis	0.00213	0.00539	CcSEcCtD
Terlipressin—Vomiting—Diphenhydramine—atopic dermatitis	0.00213	0.00539	CcSEcCtD
Terlipressin—Headache—Diphenhydramine—atopic dermatitis	0.0021	0.00531	CcSEcCtD
Terlipressin—Headache—Dimenhydrinate—atopic dermatitis	0.0021	0.00531	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00208	0.00344	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00207	0.00342	CbGpPWpGaD
Terlipressin—Vomiting—Pimecrolimus—atopic dermatitis	0.00206	0.00521	CcSEcCtD
Terlipressin—Pulmonary oedema—Prednisone—atopic dermatitis	0.00204	0.00517	CcSEcCtD
Terlipressin—Abdominal pain—Loratadine—atopic dermatitis	0.00204	0.00516	CcSEcCtD
Terlipressin—Headache—Pimecrolimus—atopic dermatitis	0.00203	0.00514	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00202	0.00333	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.002	0.00507	CcSEcCtD
Terlipressin—Nausea—Dimenhydrinate—atopic dermatitis	0.00199	0.00504	CcSEcCtD
Terlipressin—Nausea—Diphenhydramine—atopic dermatitis	0.00199	0.00504	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CXCL10—atopic dermatitis	0.00198	0.00327	CbGpPWpGaD
Terlipressin—Dyspnoea—Mometasone—atopic dermatitis	0.00197	0.005	CcSEcCtD
Terlipressin—Cardiac failure—Dexamethasone—atopic dermatitis	0.00196	0.00496	CcSEcCtD
Terlipressin—Cardiac failure—Betamethasone—atopic dermatitis	0.00196	0.00496	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCR3—atopic dermatitis	0.00194	0.00321	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCR3—atopic dermatitis	0.00193	0.00319	CbGpPWpGaD
Terlipressin—Nausea—Pimecrolimus—atopic dermatitis	0.00192	0.00487	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CCL22—atopic dermatitis	0.0019	0.00313	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL22—atopic dermatitis	0.00188	0.00311	CbGpPWpGaD
Terlipressin—Hypertension—Tacrolimus—atopic dermatitis	0.00186	0.00472	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—CCL27—atopic dermatitis	0.00186	0.00308	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.00185	0.00305	CbGpPWpGaD
Terlipressin—Chest pain—Tacrolimus—atopic dermatitis	0.00184	0.00465	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.00182	0.00462	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00182	0.003	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.0018	0.00298	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00179	0.00296	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL11—atopic dermatitis	0.00176	0.00291	CbGpPWpGaD
Terlipressin—Diarrhoea—Loratadine—atopic dermatitis	0.00176	0.00447	CcSEcCtD
Terlipressin—Abdominal pain—Mometasone—atopic dermatitis	0.00175	0.00443	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—FCER2—atopic dermatitis	0.00174	0.00287	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.00174	0.0044	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—TAC1—atopic dermatitis	0.00173	0.00286	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—NPS—atopic dermatitis	0.00173	0.00286	CbGpPWpGaD
Terlipressin—Myocardial infarction—Prednisolone—atopic dermatitis	0.00173	0.00438	CcSEcCtD
Terlipressin—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00173	0.00437	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—TAC1—atopic dermatitis	0.00172	0.00284	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—NPS—atopic dermatitis	0.00172	0.00284	CbGpPWpGaD
Terlipressin—Tachycardia—Tacrolimus—atopic dermatitis	0.00172	0.00435	CcSEcCtD
Terlipressin—Skin disorder—Tacrolimus—atopic dermatitis	0.00171	0.00433	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CCL5—atopic dermatitis	0.0017	0.00281	CbGpPWpGaD
Terlipressin—Cardiac failure—Prednisone—atopic dermatitis	0.0017	0.00432	CcSEcCtD
Terlipressin—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.0017	0.0043	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CXCR3—atopic dermatitis	0.0017	0.0028	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL27—atopic dermatitis	0.00169	0.00279	CbGpPWpGaD
Terlipressin—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.00169	0.00428	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00169	0.00278	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL27—atopic dermatitis	0.00168	0.00277	CbGpPWpGaD
Terlipressin—Vomiting—Loratadine—atopic dermatitis	0.00164	0.00415	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00163	0.00269	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00162	0.00267	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00162	0.00267	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL22—atopic dermatitis	0.00162	0.00267	CbGpPWpGaD
Terlipressin—Headache—Loratadine—atopic dermatitis	0.00161	0.00409	CcSEcCtD
Terlipressin—Bradycardia—Prednisolone—atopic dermatitis	0.00161	0.00408	CcSEcCtD
Terlipressin—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.0016	0.00405	CcSEcCtD
Terlipressin—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.00159	0.00404	CcSEcCtD
Terlipressin—Myocardial infarction—Triamcinolone—atopic dermatitis	0.00159	0.00403	CcSEcCtD
Terlipressin—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.00159	0.00402	CcSEcCtD
Terlipressin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00159	0.00402	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CCR3—atopic dermatitis	0.00158	0.00262	CbGpPWpGaD
Terlipressin—Bradycardia—Hydrocortisone—atopic dermatitis	0.00157	0.00399	CcSEcCtD
Terlipressin—Dyspnoea—Tacrolimus—atopic dermatitis	0.00157	0.00398	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00155	0.00256	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00154	0.00254	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CCR5—atopic dermatitis	0.00154	0.00254	CbGpPWpGaD
Terlipressin—Nausea—Loratadine—atopic dermatitis	0.00153	0.00388	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00152	0.00385	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CCL17—atopic dermatitis	0.00152	0.00251	CbGpPWpGaD
Terlipressin—Diarrhoea—Mometasone—atopic dermatitis	0.00151	0.00383	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CCL17—atopic dermatitis	0.00151	0.00249	CbGpPWpGaD
Terlipressin—Bradycardia—Triamcinolone—atopic dermatitis	0.00148	0.00375	CcSEcCtD
Terlipressin—Bradycardia—Methylprednisolone—atopic dermatitis	0.00148	0.00375	CcSEcCtD
Terlipressin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00147	0.00373	CcSEcCtD
Terlipressin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00145	0.00368	CcSEcCtD
Terlipressin—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.00145	0.00367	CcSEcCtD
Terlipressin—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.00145	0.00367	CcSEcCtD
Terlipressin—Myocardial infarction—Dexamethasone—atopic dermatitis	0.00144	0.00365	CcSEcCtD
Terlipressin—Myocardial infarction—Betamethasone—atopic dermatitis	0.00144	0.00365	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CCL27—atopic dermatitis	0.00144	0.00238	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCR3—atopic dermatitis	0.00144	0.00238	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—NPS—atopic dermatitis	0.00141	0.00233	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—TAC1—atopic dermatitis	0.00141	0.00233	CbGpPWpGaD
Terlipressin—Vomiting—Mometasone—atopic dermatitis	0.00141	0.00356	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.0014	0.00231	CbGpPWpGaD
Terlipressin—Abdominal pain—Tacrolimus—atopic dermatitis	0.00139	0.00353	CcSEcCtD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00139	0.00229	CbGpPWpGaD
Terlipressin—Headache—Mometasone—atopic dermatitis	0.00139	0.00351	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00138	0.00229	CbGpPWpGaD
Terlipressin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00138	0.00349	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL10—atopic dermatitis	0.00137	0.00227	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.00136	0.00225	CbGpPWpGaD
Terlipressin—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.00135	0.00342	CcSEcCtD
Terlipressin—Malnutrition—Hydrocortisone—atopic dermatitis	0.00135	0.00341	CcSEcCtD
Terlipressin—Bradycardia—Dexamethasone—atopic dermatitis	0.00134	0.00341	CcSEcCtD
Terlipressin—Bradycardia—Betamethasone—atopic dermatitis	0.00134	0.00341	CcSEcCtD
Terlipressin—Angiopathy—Methylprednisolone—atopic dermatitis	0.00132	0.00334	CcSEcCtD
Terlipressin—Nausea—Mometasone—atopic dermatitis	0.00131	0.00333	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—IL5—atopic dermatitis	0.00131	0.00217	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL17—atopic dermatitis	0.00129	0.00214	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NPS—atopic dermatitis	0.00128	0.00212	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—TAC1—atopic dermatitis	0.00128	0.00212	CbGpPWpGaD
Terlipressin—Malnutrition—Methylprednisolone—atopic dermatitis	0.00126	0.0032	CcSEcCtD
Terlipressin—Acute coronary syndrome—Prednisone—atopic dermatitis	0.00126	0.0032	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00126	0.00208	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCR3—atopic dermatitis	0.00126	0.00208	CbGpPWpGaD
Terlipressin—Myocardial infarction—Prednisone—atopic dermatitis	0.00126	0.00318	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00125	0.00207	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL11—atopic dermatitis	0.00122	0.00202	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00122	0.00201	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL11—atopic dermatitis	0.00121	0.00201	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FCER2—atopic dermatitis	0.00121	0.00199	CbGpPWpGaD
Terlipressin—Diarrhoea—Tacrolimus—atopic dermatitis	0.0012	0.00305	CcSEcCtD
Terlipressin—Angiopathy—Betamethasone—atopic dermatitis	0.0012	0.00304	CcSEcCtD
Terlipressin—Angiopathy—Dexamethasone—atopic dermatitis	0.0012	0.00304	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—FCER2—atopic dermatitis	0.0012	0.00198	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL5—atopic dermatitis	0.00119	0.00197	CbGpPWpGaD
Terlipressin—Hypertension—Prednisolone—atopic dermatitis	0.00119	0.00301	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCL5—atopic dermatitis	0.00118	0.00195	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL5—atopic dermatitis	0.00117	0.00194	CbGpPWpGaD
Terlipressin—Bradycardia—Prednisone—atopic dermatitis	0.00117	0.00297	CcSEcCtD
Terlipressin—Hypertension—Hydrocortisone—atopic dermatitis	0.00116	0.00294	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—KIF3A—atopic dermatitis	0.00115	0.0019	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00114	0.00288	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CCL22—atopic dermatitis	0.00112	0.00185	CbGpPWpGaD
Terlipressin—Vomiting—Tacrolimus—atopic dermatitis	0.00112	0.00284	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00112	0.00185	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL22—atopic dermatitis	0.00111	0.00184	CbGpPWpGaD
Terlipressin—Headache—Tacrolimus—atopic dermatitis	0.0011	0.00279	CcSEcCtD
Terlipressin—Tachycardia—Prednisolone—atopic dermatitis	0.0011	0.00278	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR3—atopic dermatitis	0.0011	0.00181	CbGpPWpGaD
Terlipressin—Hypertension—Triamcinolone—atopic dermatitis	0.00109	0.00277	CcSEcCtD
Terlipressin—Hypertension—Methylprednisolone—atopic dermatitis	0.00109	0.00277	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.00109	0.0018	CbGpPWpGaD
Terlipressin—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.00108	0.00273	CcSEcCtD
Terlipressin—Tachycardia—Hydrocortisone—atopic dermatitis	0.00107	0.00272	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00107	0.00271	CcSEcCtD
Terlipressin—Skin disorder—Hydrocortisone—atopic dermatitis	0.00107	0.0027	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCR5—atopic dermatitis	0.00106	0.00176	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCR5—atopic dermatitis	0.00106	0.00175	CbGpPWpGaD
Terlipressin—Nausea—Tacrolimus—atopic dermatitis	0.00105	0.00265	CcSEcCtD
Terlipressin—Angiopathy—Prednisone—atopic dermatitis	0.00104	0.00264	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CMA1—atopic dermatitis	0.00104	0.00172	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL11—atopic dermatitis	0.00104	0.00172	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL10—atopic dermatitis	0.00102	0.00168	CbGpPWpGaD
Terlipressin—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00101	0.00256	CcSEcCtD
Terlipressin—Tachycardia—Triamcinolone—atopic dermatitis	0.00101	0.00256	CcSEcCtD
Terlipressin—Tachycardia—Methylprednisolone—atopic dermatitis	0.00101	0.00255	CcSEcCtD
Terlipressin—Skin disorder—Methylprednisolone—atopic dermatitis	0.001	0.00254	CcSEcCtD
Terlipressin—Malnutrition—Prednisone—atopic dermatitis	0.001	0.00254	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CCL27—atopic dermatitis	0.000999	0.00165	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR3—atopic dermatitis	0.000997	0.00165	CbGpPWpGaD
Terlipressin—Hypertension—Betamethasone—atopic dermatitis	0.000993	0.00252	CcSEcCtD
Terlipressin—Hypertension—Dexamethasone—atopic dermatitis	0.000993	0.00252	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CCL27—atopic dermatitis	0.000992	0.00164	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000989	0.00163	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT6—atopic dermatitis	0.00098	0.00162	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000978	0.00162	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—NPS—atopic dermatitis	0.000978	0.00162	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000971	0.0016	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000971	0.0016	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CCL5—atopic dermatitis	0.000963	0.00159	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000959	0.00158	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000952	0.00157	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000948	0.0024	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CXCL8—atopic dermatitis	0.000928	0.00153	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000925	0.00153	CbGpPWpGaD
Terlipressin—Dyspnoea—Triamcinolone—atopic dermatitis	0.000922	0.00234	CcSEcCtD
Terlipressin—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00092	0.00233	CcSEcCtD
Terlipressin—Nervous system disorder—Betamethasone—atopic dermatitis	0.00092	0.00233	CcSEcCtD
Terlipressin—Tachycardia—Dexamethasone—atopic dermatitis	0.000916	0.00232	CcSEcCtD
Terlipressin—Tachycardia—Betamethasone—atopic dermatitis	0.000916	0.00232	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—IL5—atopic dermatitis	0.000909	0.0015	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000903	0.00149	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL17—atopic dermatitis	0.000896	0.00148	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL17—atopic dermatitis	0.00089	0.00147	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NPS—atopic dermatitis	0.000888	0.00147	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—TAC1—atopic dermatitis	0.000888	0.00147	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000882	0.00146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NPS—atopic dermatitis	0.000882	0.00146	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL5—atopic dermatitis	0.000874	0.00144	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000871	0.00144	CbGpPWpGaD
Terlipressin—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000868	0.0022	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CCR5—atopic dermatitis	0.000868	0.00143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000865	0.00143	CbGpPWpGaD
Terlipressin—Hypertension—Prednisone—atopic dermatitis	0.000864	0.00219	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CCR3—atopic dermatitis	0.000849	0.0014	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000847	0.00215	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000845	0.0014	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000839	0.00139	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL5—atopic dermatitis	0.000826	0.00136	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL5—atopic dermatitis	0.00082	0.00135	CbGpPWpGaD
Terlipressin—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000816	0.00207	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00081	0.00205	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00081	0.00205	CcSEcCtD
Terlipressin—Nervous system disorder—Prednisone—atopic dermatitis	0.000801	0.00203	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—KIF3A—atopic dermatitis	0.000799	0.00132	CbGpPWpGaD
Terlipressin—Tachycardia—Prednisone—atopic dermatitis	0.000798	0.00202	CcSEcCtD
Terlipressin—Skin disorder—Prednisone—atopic dermatitis	0.000794	0.00201	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000793	0.00131	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCR5—atopic dermatitis	0.000788	0.0013	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000784	0.0013	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000775	0.00128	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00077	0.00127	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TAC1—atopic dermatitis	0.000757	0.00125	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NPS—atopic dermatitis	0.000757	0.00125	CbGpPWpGaD
Terlipressin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000751	0.0019	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CXCR3—atopic dermatitis	0.000742	0.00123	CbGpPWpGaD
Terlipressin—Abdominal pain—Betamethasone—atopic dermatitis	0.000742	0.00188	CcSEcCtD
Terlipressin—Abdominal pain—Dexamethasone—atopic dermatitis	0.000742	0.00188	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CMA1—atopic dermatitis	0.000722	0.00119	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL11—atopic dermatitis	0.000722	0.00119	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL11—atopic dermatitis	0.000717	0.00118	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CMA1—atopic dermatitis	0.000717	0.00118	CbGpPWpGaD
Terlipressin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000706	0.00179	CcSEcCtD
Terlipressin—Headache—Prednisolone—atopic dermatitis	0.000705	0.00179	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL10—atopic dermatitis	0.000704	0.00116	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL5—atopic dermatitis	0.000704	0.00116	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000699	0.00115	CbGpPWpGaD
Terlipressin—Vomiting—Hydrocortisone—atopic dermatitis	0.000698	0.00177	CcSEcCtD
Terlipressin—Headache—Hydrocortisone—atopic dermatitis	0.000688	0.00174	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—STAT6—atopic dermatitis	0.000679	0.00112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT6—atopic dermatitis	0.000674	0.00111	CbGpPWpGaD
Terlipressin—Nausea—Prednisolone—atopic dermatitis	0.000668	0.00169	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—CCL5—atopic dermatitis	0.000667	0.0011	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000663	0.00109	CbGpPWpGaD
Terlipressin—Vomiting—Triamcinolone—atopic dermatitis	0.000658	0.00167	CcSEcCtD
Terlipressin—Vomiting—Methylprednisolone—atopic dermatitis	0.000656	0.00166	CcSEcCtD
Terlipressin—Nausea—Hydrocortisone—atopic dermatitis	0.000652	0.00165	CcSEcCtD
Terlipressin—Headache—Triamcinolone—atopic dermatitis	0.000648	0.00164	CcSEcCtD
Terlipressin—Headache—Methylprednisolone—atopic dermatitis	0.000646	0.00164	CcSEcCtD
Terlipressin—Abdominal pain—Prednisone—atopic dermatitis	0.000646	0.00164	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000643	0.00106	CbGpPWpGaD
Terlipressin—Diarrhoea—Dexamethasone—atopic dermatitis	0.000642	0.00163	CcSEcCtD
Terlipressin—Diarrhoea—Betamethasone—atopic dermatitis	0.000642	0.00163	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000641	0.00106	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000639	0.00106	CbGpPWpGaD
Terlipressin—Nausea—Triamcinolone—atopic dermatitis	0.000614	0.00156	CcSEcCtD
Terlipressin—Nausea—Methylprednisolone—atopic dermatitis	0.000613	0.00155	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CCL5—atopic dermatitis	0.000606	0.001	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL5—atopic dermatitis	0.000602	0.000994	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000601	0.000993	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL10—atopic dermatitis	0.0006	0.000991	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000597	0.000986	CbGpPWpGaD
Terlipressin—Vomiting—Betamethasone—atopic dermatitis	0.000597	0.00151	CcSEcCtD
Terlipressin—Vomiting—Dexamethasone—atopic dermatitis	0.000597	0.00151	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CCR3—atopic dermatitis	0.000589	0.000973	CbGpPWpGaD
Terlipressin—Headache—Betamethasone—atopic dermatitis	0.000588	0.00149	CcSEcCtD
Terlipressin—Headache—Dexamethasone—atopic dermatitis	0.000588	0.00149	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CCR3—atopic dermatitis	0.000585	0.000966	CbGpPWpGaD
Terlipressin—Diarrhoea—Prednisone—atopic dermatitis	0.000559	0.00142	CcSEcCtD
Terlipressin—Nausea—Dexamethasone—atopic dermatitis	0.000557	0.00141	CcSEcCtD
Terlipressin—Nausea—Betamethasone—atopic dermatitis	0.000557	0.00141	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CCR5—atopic dermatitis	0.000546	0.000902	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCR5—atopic dermatitis	0.000542	0.000896	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TAC1—atopic dermatitis	0.000525	0.000867	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NPS—atopic dermatitis	0.000525	0.000867	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000524	0.000866	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TAC1—atopic dermatitis	0.000521	0.000861	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NPS—atopic dermatitis	0.000521	0.000861	CbGpPWpGaD
Terlipressin—Vomiting—Prednisone—atopic dermatitis	0.00052	0.00132	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CCL5—atopic dermatitis	0.000517	0.000853	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCR3—atopic dermatitis	0.000515	0.00085	CbGpPWpGaD
Terlipressin—Headache—Prednisone—atopic dermatitis	0.000512	0.0013	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CXCR3—atopic dermatitis	0.000511	0.000844	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—atopic dermatitis	0.000501	0.000828	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL5—atopic dermatitis	0.000488	0.000806	CbGpPWpGaD
Terlipressin—Nausea—Prednisone—atopic dermatitis	0.000485	0.00123	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—IL5—atopic dermatitis	0.000484	0.0008	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NGF—atopic dermatitis	0.000478	0.00079	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL8—atopic dermatitis	0.000476	0.000787	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCR5—atopic dermatitis	0.000465	0.000769	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—atopic dermatitis	0.000455	0.000752	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL10—atopic dermatitis	0.000416	0.000687	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL10—atopic dermatitis	0.000413	0.000682	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NFKBIA—atopic dermatitis	0.000395	0.000652	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000364	0.000601	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000361	0.000596	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL5—atopic dermatitis	0.000358	0.000592	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL5—atopic dermatitis	0.000355	0.000587	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—atopic dermatitis	0.000347	0.000574	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—atopic dermatitis	0.000345	0.00057	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NGF—atopic dermatitis	0.000332	0.000548	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—atopic dermatitis	0.00033	0.000545	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NGF—atopic dermatitis	0.000329	0.000544	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000328	0.000541	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCR5—atopic dermatitis	0.000323	0.000533	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCR5—atopic dermatitis	0.00032	0.000529	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—atopic dermatitis	0.000316	0.000521	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—atopic dermatitis	0.000313	0.000517	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—atopic dermatitis	0.000281	0.000465	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NFKBIA—atopic dermatitis	0.000273	0.000452	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000272	0.000449	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—atopic dermatitis	0.000269	0.000444	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—atopic dermatitis	0.000268	0.000442	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK8—atopic dermatitis	0.000248	0.000409	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—atopic dermatitis	0.000195	0.000322	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—atopic dermatitis	0.000194	0.00032	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—atopic dermatitis	0.000186	0.000308	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—atopic dermatitis	0.000185	0.000306	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—atopic dermatitis	0.000185	0.000306	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—atopic dermatitis	0.000184	0.000304	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK8—atopic dermatitis	0.000172	0.000283	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK8—atopic dermatitis	0.00017	0.000281	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—atopic dermatitis	0.000158	0.000261	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—atopic dermatitis	0.00011	0.000181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—atopic dermatitis	0.000109	0.00018	CbGpPWpGaD
